FUNDING CANCER - Assay Development and Screening for Discovery of Chemical Probes, Drugs, or Immunomodulators
Sponsor: NIH
Description: With this opportunity, the National Cancer Institute intends to stimulate research in discovery and development of novel, small molecules for cancer. Molecules discovered through this NOFO may be used to probe cancer biology, to validate cancer targets, or as the basis for optimized drugs. Stages of discovery research covered by this opportunity include 1) development of the primary screen assays and testing an initial pilot screen; 2) primary screen implementation to identify initial screening hits; and 3) hit validation using a series of assays and initial medicinal chemistry inspection to prioritize the hit set.
- Applications Due:
- February 5, 2025
- June 5, 2025
- October 5, 2025
- February 5, 2026
- June 5, 2026
To view all current UVACCC funding opportunities, please click here.
For all open cancer-related funding opportunities, please click here.